Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. TSLA
2. SPY
3. META
4. INTC
5. HOOD
6. STZ
7. FUTU
8. AMZN
9. MSFT
10. SPCX

Go back to Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Syros Pharmaceuticals (SYRS) Tops Q1 EPS by 7c

May 16, 2022 7:31 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q1 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $5.5 million versus the consensus estimate of $4.92 million.

For earnings history and earnings-related data on Syros Pharmaceuticals (SYRS) click here.

... More